← Back to home

ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR

Clinical trials for ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR explained in plain language.

Never miss a new study

Get alerted when new ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR trials appear

Sign up with your email to follow new studies for ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Virus therapy targets Hard-to-Treat tumors in early trial

Disease control Ongoing

This early-stage study tests the safety of a new virus-based drug called EM-I-2024 in 24 adults with advanced solid tumors that cannot be removed by surgery and have not responded to other treatments. The drug is given either through a vein or directly into the artery feeding the…

Matched conditions: ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR

Phase: PHASE1 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control

Last updated May 17, 2026 07:36 UTC

ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR

Get alerted when new ASSESS THE SAFETY AND TOLERABILITY OF VARIOUS DOSES AND DOSING SCHEDULES OF ENTEROMIX IN PATIENTS WITH A HISTOLOGICALLY CONFIRMED SOLID TUMOR trials appear

Virus therapy targets Hard-to-Treat tumors in early trial